Trinity Biotech plc
TRIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$31,789 | -$24,018 | -$41,009 | $875 |
| Dep. & Amort. | $1,865 | $1,776 | $2,333 | $2,744 |
| Deferred Tax | $486 | -$59 | -$192 | -$167 |
| Stock-Based Comp. | $1,316 | $2,069 | $1,755 | $1,100 |
| Change in WC | $6,188 | -$2,693 | -$1,662 | -$172 |
| Other Non-Cash | $17,743 | $11,368 | $37,854 | $8,858 |
| Operating Cash Flow | -$4,191 | -$11,557 | -$921 | $13,238 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$405 | -$803 | -$5,977 | -$8,691 |
| Net Acquisitions | -$12,904 | $28,160 | $0 | $0 |
| Inv. Purchases | $0 | -$700 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$9,659 | -$1,901 | $0 | $0 |
| Investing Cash Flow | -$22,968 | $24,756 | -$5,977 | -$8,691 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $27,673 | -$7,368 | -$27,044 | -$2,939 |
| Stock Issued | $7,391 | $0 | $25,336 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,254 | -$8,674 | -$10,614 | -$3,080 |
| Financing Cash Flow | $28,810 | -$16,042 | -$12,322 | -$6,019 |
| Forex Effect | -$175 | -$44 | -$112 | $55 |
| Net Chg. in Cash | $1,476 | -$2,887 | -$19,332 | -$1,417 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,691 | $6,578 | $25,910 | $27,327 |
| End Cash | $5,167 | $3,691 | $6,578 | $25,910 |
| Free Cash Flow | -$14,255 | -$12,360 | -$6,898 | $4,547 |